公司
TauRx Pharmaceutical (HK) Ltd is a commercial-stage biopharmaceutical company dedicated to developing innovative solutions for neurodegenerative diseases associated with pathological protein aggregation. Through decades of scientific innovation, TauRx has advanced hydromethylthionine mesylate (HMTM), a novel tau-directed therapy designed to modify disease progression rather than simply manage symptoms.The expansion of our presence at Hong Kong Science Park reflects TauRx's commitment to advancing innovative healthcare solutions across Asia. Through strategic partnerships, rigorous scientific development, and adherence to the highest regulatory and ethical standards, we strive to transform breakthrough science into meaningful benefits for patients, caregivers, and healthcare systems worldwide.
